PICOT STATEMENT PAPER
A PICOT starts with a designated patient population in a particular clinical area and identifies clinical problems or issues that arise from clinical care. The intervention should be an independent, specified nursing change intervention. The intervention cannot require a provider prescription. Include a comparison to a patient population not currently receiving the intervention, and specify the timeframe needed to implement the change process.
Formulate a PICOT statement using the PICOT and the PICOT statement will provide a framework for your capstone project.
In a paper of 550 words, clearly identify the clinical problem and how it can result in a positive patient outcome.
Make sure to address the following on the PICOT statement:
1. Evidence-Based Solution
2. Nursing Intervention
3. Patient Care
4. Health Care Agency
5. Nursing Practice
Prepare this assignment according to the guidelines found in the APA Style Guide
The purpose of this paper is a proposal of the evidence-based practice that will be applied in diagnosis, treatment, and medication of Drug-Induced Mental Disorder. The research shall base on the evidence-base practice on education and sensitization a vulnerable group of individuals in society.
Submit a summary of six of your articles on drug induced mental disorders and discuss one strength and one weakness to each of these six articles on why the article may or may not provide sufficient evidence for your practice change.
Utilize the following references:
Brosey, E. A., & Woodward, N. D. (2017). Neuroanatomical correlates of perceptual aberrations in psychosis. Schizophrenia research, 179, 125-131. Retrieved from https://www.sciencedirect.com/science/article/abs/pii/S0920996416304509
Chie, Q. T., Tam, C. L., Bonn, G., Wong, C. P., Dang, H. M., & Khairuddin, R. (2015). Drug abuse, relapse, and prevention education in Malaysia: perspective of university students through a mixed methods approach. Frontiers in psychiatry, 6, 65. Retrieved from https://www.frontiersin.org/articles/10.3389/fpsyt.2015.00065/full.
Fuller, C. M., Vlahov, D., Arria, A. M., Ompad, D. C., Garfein, R., & Strathdee, S. A. (2016). Factors associated with adolescent initiation of injection drug use. Public health reports. Retrieved from https://journals.sagepub.com/doi/abs/10.1093/phr/116.S1.136.
Hides, L., Dawe, S., McKetin, R., Kavanagh, D. J., Young, R. M., Teesson, M., & Saunders, J. B. (2015). Primary and substance-induced psychotic disorders in methamphetamine users. Psychiatry research, 226(1), 91-96. Retrieved from https://www.sciencedirect.com/science/articles/abs/pii/S016517811401004X
Iqbal, E., Mallah, R., Jackson, R. G., Ball, M., Ibrahim, Z. M., Broadbent, M., … & Dobson, R. J. (2015). Identification of adverse drug events from free text electronic patient records and information in a large mental health case register. PloS one, 10(8), e0134208. Retrieved from https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0134208
Kirby, B. J., Symonds, W. T., Kearney, B. P., & Mathias, A. A. (2015). Pharmacokinetic, pharmacodynamic, and drug-interaction profile of the hepatitis C virus NS5B polymerase inhibitor sofosbuvir. Clinical pharmacokinetics, 54(7), 677-690. Retrieved from https://link.springer.com/article/10.1007/s40262-015-0261-7.
Wong, C., Odom, S. L., Hume, K. A., Cox, A. W., Fettig, A., Kucharczyk, S., … & Schultz, T. R. (2015). Evidence-based practices for children, youth, and young adults with autism spectrum disorder: A comprehensive review. Journal of autism and developmental disorders, 45(7), 1951-1966. Retrieved from https://link.springer.com/article/10.1007/s10803-014-2351-z.